Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLeonaBio Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$3.73 | -$0.83 | -$2.28 |
| Q2 2026 | 2 | -$1.12 | -$1.12 | -$1.12 |
| Q3 2026 | 2 | -$0.71 | -$0.71 | -$0.71 |
| Q4 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q1 2027 | 1 | -$0.67 | -$0.67 | -$0.67 |
| Q2 2027 | 1 | -$0.70 | -$0.70 | -$0.70 |
| Q3 2027 | 1 | -$0.66 | -$0.66 | -$0.66 |
| Q4 2027 | 1 | -$0.52 | -$0.52 | -$0.52 |
LeonaBio Inc. Earnings Date And Information
LeonaBio Inc. last posted its earnings results on Thursday, May 7th, 2026. The company reported $-1.73 earnings per share for the quarter, topping analysts' consensus estimates of $-2.2772 by $0.5472. The company had revenue of 0 for the quarter and had revenue of 0 for the year. LeonaBio Inc. has generated $-25 earnings per share over the last year ($-24.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.27. LeonaBio Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
LeonaBio Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$2.28 | -$7.71 | -5.43 | $0 | $0 |
| 03/31/2026 | Q4 2025 | N/A | -$18.94 | N/A | $0 | $0 |
| 11/06/2025 | Q3 2025 | -$1.06 | -$1.68 | -0.62 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$1.80 | -$1.78 | 0.02 | N/A | $0 |
| 05/09/2025 | Q1 2025 | -$0.20 | -$2.30 | -2.1 | N/A | $0 |
| 02/27/2025 | Q4 2024 | -$0.23 | -$3.90 | -3.67 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.80 | -$7.50 | -6.7 | N/A | $0 |
| 08/01/2024 | Q2 2024 | -$0.75 | -$7.00 | -6.25 | N/A | $0 |
| 05/15/2024 | Q1 2024 | -$0.80 | -$6.90 | -6.1 | N/A | $0 |
| 02/22/2024 | Q4 2023 | -$0.96 | -$7.20 | -6.24 | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.87 | -$8.70 | -7.83 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.81 | -$7.80 | -6.99 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.66 | -$6.80 | -6.14 | N/A | $0 |
| 03/23/2023 | Q4 2022 | -$0.70 | -$6.80 | -6.1 | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$0.67 | -$4.30 | -3.63 | N/A | $0 |
| 08/15/2022 | Q2 2022 | -$0.66 | -$6.50 | -5.84 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.63 | -$4.90 | -4.27 | N/A | $0 |
| 03/28/2022 | Q4 2021 | N/A | -$4.40 | N/A | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$0.50 | -$4.20 | -3.7 | N/A | $0 |
| 08/16/2021 | Q2 2021 | -$0.37 | -$3.80 | -3.43 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
LeonaBio Inc. Earnings: FAQ's
In the previous quarter, LeonaBio Inc. (:LONA) reported $-1.73 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.2772 by $0.5472.
The conference call for LeonaBio Inc.'s latest earnings report can be listened to online.
The conference call transcript for LeonaBio Inc.'s latest earnings report can be read online.
LeonaBio Inc. (:LONA) has a recorded net income of $-105,609,000.LeonaBio Inc. has generated $-24.7 earnings per share over the last four quarters.
LeonaBio Inc. (:LONA) has a price-to-earnings ratio of -0.27 and price/earnings-to-growth ratio is 0.